.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Express Scripts
Fish and Richardson
Chinese Patent Office
Medtronic
Teva
AstraZeneca
Argus Health
Novartis

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201615

« Back to Dashboard

NDA 201615 describes CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, which is a drug marketed by Perrigo Israel and Tolmar and is included in two NDAs. It is available from one supplier. Additional details are available on the CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE profile page.

The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene hydrate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene hydrate profile page.

Summary for 201615

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 201615

Ingredient-typeVitamin D
Mechanism of ActionCorticosteroid Hormone Receptor Agonists

Suppliers and Packaging for NDA: 201615

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 201615 ANDA Sandoz Inc. 0781-7165 0781-7165-35 1 TUBE in 1 CARTON (0781-7165-35) > 60 g in 1 TUBE
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 201615 ANDA Sandoz Inc. 0781-7165 0781-7165-95 1 TUBE in 1 CARTON (0781-7165-95) > 100 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.064%;0.005%
Approval Date:Jan 14, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Federal Trade Commission
Medtronic
Johnson and Johnson
Queensland Health
US Department of Justice
Covington
McKesson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot